Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Nixon

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Cell|September 12, 2001
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinantsN F Rose, P A Marx, A Luckay, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Mucosal Immunology|April 7, 2016
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infectionD Paquin-Proulx, C Ching, I Vujkovic-Cvijin, et al.
Virology|May 4, 2000
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjectsB L Shacklett, T J Beadle, P A Pacheco, et al.
AIDS Research and Human Retroviruses|January 11, 2000
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithmX Jin, C G Roberts, D F Nixon, et al.
Journal of Virology|December 16, 1998
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1W B Dyer, G S Ogg, M A Demoitie, et al.
The Journal of Clinical Investigation|July 20, 1999
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsM V Dhodapkar, R M Steinman, M Sapp, et al.
The Journal of Infectious Diseases|July 7, 2000
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in childrenH M Spiegel, R Chandwani, M E Sheehy, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjectsB L Shacklett, T J Beadle, P A Pacheco, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cell|September 12, 2001
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinantsN F Rose, P A Marx, A Luckay, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Mucosal Immunology|April 7, 2016
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infectionD Paquin-Proulx, C Ching, I Vujkovic-Cvijin, et al.
Virology|May 4, 2000
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjectsB L Shacklett, T J Beadle, P A Pacheco, et al.
AIDS Research and Human Retroviruses|January 11, 2000
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithmX Jin, C G Roberts, D F Nixon, et al.
Journal of Virology|December 16, 1998
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1W B Dyer, G S Ogg, M A Demoitie, et al.
The Journal of Clinical Investigation|July 20, 1999
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsM V Dhodapkar, R M Steinman, M Sapp, et al.
The Journal of Infectious Diseases|July 7, 2000
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in childrenH M Spiegel, R Chandwani, M E Sheehy, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjectsB L Shacklett, T J Beadle, P A Pacheco, et al.
Journal of Virology|October 17, 2001
Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120C E Hioe, M Tuen, P C Chien, et al.
Pageof 6